Neuroblastoma Global Clinical Trials Review, H1, 2016

Tuesday, August 2, 2016 Clinical Trials News J E 4

LONDON, Aug. 1, 2016 /PRNewswire/ -- Neuroblastoma Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, "Neuroblastoma Global Clinical Trials Review, H1, 2016" provides an overview of Neuroblastoma clinical trials scenario. This report provides top line data relating to the clinical trials on Neuroblastoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.Scope- The report provides a snapshot of the global clinical trials landscape- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment- The Report provides enrollment trends for the past five years- Report provides latest news for the past three months*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.Reasons to buy- Assists in formulating key business strategies with regards to investment- Helps in identifying prominent locations for conducting clinical trials which saves time and cost- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities- Supports understanding of trials count and enrollment trends by country in global therapeutics market- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials- Facilitates clinical trial assessment of the indication on a global, regional and country level*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.Download the full report: ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information: Sarah Smith Research Advisor at Email:  Tel: +44 208 816 85 48 Website:

To view the original version on PR Newswire, visit:

SOURCE ReportBuyer



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Bleeding Disorders Treatment Market by Type, Drug ...
Uncaring Or Uneducated? Pregnant Mothers Blase Abo...